FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

19466711000001104: Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Aug 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
65812601000001117 Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
103456201000001112 Emla 5% cream (Aspen Pharma Trading Ltd) 25 gram 5 x 5g + 12 dressings en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Has excipient Polyoxyl castor oil false Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Is a Lidocaine 2.5% / Prilocaine 2.5% cream 25 gram true Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Has AMP Emla 5% cream (AstraZeneca) true Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Has excipient Excipient not declared false Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Has specific active ingredient Prilocaine true Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Has specific active ingredient Lidocaine true Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Has dispensed dose form Cream true Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Emla 5% cream (AstraZeneca UK Ltd) 25 gram 5 x 5g + 12 dressings Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start